Literature DB >> 8435480

The nude mouse as an in vivo model for human breast cancer invasion and metastasis.

N Brünner1, B Boysen, J Rømer, M Spang-Thomsen.   

Abstract

Human breast cancer xenografts only rarely invade and metastasize in nude mice, and have therefore only had limited use as a model for studying mechanisms involved in breast cancer spreading. However, recent reports describe differences not only between various cell lines but also between strains of immune-deficient mice in terms of providing a model for studies of the invasive and metastatic capability of human breast cancer xenografts. Genetic labelling of human cancer cells with the lacZ gene is described as a specific and highly sensitive method for identification of micrometastases in such a model.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435480     DOI: 10.1007/bf01833265

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  26 in total

1.  Comparative studies between nude and scid mice on the growth and metastatic behavior of xenografted human tumors.

Authors:  X Xie; N Brünner; G Jensen; J Albrectsen; B Gotthardsen; J Rygaard
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

2.  Heterotransplantation of a human malignant tumour to "Nude" mice.

Authors:  J Rygaard; C O Povlsen
Journal:  Acta Pathol Microbiol Scand       Date:  1969

3.  Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ.

Authors:  G P Nolan; S Fiering; J F Nicolas; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 4.  Endocrine therapy of human breast cancer grown in nude mice.

Authors:  N Brünner; C K Osborne; M Spang-Thomsen
Journal:  Breast Cancer Res Treat       Date:  1987-12       Impact factor: 4.872

5.  The use of a genotypic marker to demonstrate clonal dominance during the growth and metastasis of a human breast carcinoma in nude mice.

Authors:  J E Price; C Bell; P Frost
Journal:  Int J Cancer       Date:  1990-05-15       Impact factor: 7.396

6.  Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

Authors:  R Clarke; N Brünner; B S Katzenellenbogen; E W Thompson; M J Norman; C Koppi; S Paik; M E Lippman; R B Dickson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  lacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis.

Authors:  N Brünner; E W Thompson; M Spang-Thomsen; J Rygaard; K Danø; J A Zwiebel
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

8.  Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.

Authors:  E W Thompson; S Paik; N Brünner; C L Sommers; G Zugmaier; R Clarke; T B Shima; J Torri; S Donahue; M E Lippman
Journal:  J Cell Physiol       Date:  1992-03       Impact factor: 6.384

9.  Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection.

Authors:  R S Kerbel; C Waghorne; M S Man; B Elliott; M L Breitman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

Review 10.  Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

View more
  13 in total

1.  Expression of molecular biomarkers in primary breast tumors implanted into a surrogate host: increased levels of cyclins correlate with tumor progression.

Authors:  G Wani; I Noyes; G E Milo; S M D'Ambrosio
Journal:  Mol Med       Date:  1997-04       Impact factor: 6.354

Review 2.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

3.  Influence of antiestrogens on the migration of breast cancer cells using an in vitro wound model.

Authors:  A C Mathew; T T Rajah; G M Hurt; S M Abbas Abidi; J J Dmytryk; J T Pento
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

4.  Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780.

Authors:  D Couissi; V Dubois; C Remacle; E Schonne; A Trouet
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

5.  Effect of MRC-5 fibroblast conditioned medium on breast cancer cell motility and invasion in vitro.

Authors:  N Heylen; R Baurain; C Remacle; A Trouet
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

Review 6.  Reporter genes in transgenic mice.

Authors:  C Cui; M A Wani; D Wight; J Kopchick; P J Stambrook
Journal:  Transgenic Res       Date:  1994-05       Impact factor: 2.788

7.  Comparing the MRI appearance of the lymph nodes and spleen in wild-type and immuno-deficient mouse strains.

Authors:  Vasiliki Economopoulos; Jennifer C Noad; Shruti Krishnamoorthy; Brian K Rutt; Paula J Foster
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

8.  Proteinase inhibitors reduce basement membrane degradation by human breast cancer cell lines.

Authors:  P S Stonelake; C E Jones; J P Neoptolemos; P R Baker
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Development of a new metastatic human breast carcinoma xenograft line.

Authors:  R R Mehta; J M Graves; A Shilkaitis; T K Das Gupta
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

10.  BRAT1 deficiency causes increased glucose metabolism and mitochondrial malfunction.

Authors:  Eui Young So; Toru Ouchi
Journal:  BMC Cancer       Date:  2014-07-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.